401
edits
Myocardial Infarction: Difference between revisions
→Non-ST-Segment Elevation Acute Coronary Syndrome
| Line 80: | Line 80: | ||
=== ''Non-ST-Segment Elevation Acute Coronary Syndrome'' === | === ''Non-ST-Segment Elevation Acute Coronary Syndrome'' === | ||
Comparable to STEMI, revascularization in NSTE-ACS relieves symptoms, shortens hospital | Comparable to STEMI, revascularization in NSTE-ACS relieves symptoms, shortens hospital | ||
stay, and improves prognosis. However, NSTE-ACS patients represent a | stay, and improves prognosis. However, NSTE-ACS patients represent a heterogeneous population, and indication and timing of revascularization depend on many factors, including the baseline risk of the patient. According to current guidelines, depending on early risk stratification a choice has to be made between a routine invasive or a selective invasive (or “conservative strategy”) <Cite>REFNAME27</Cite> | ||
| Line 97: | Line 97: | ||
Regarding treatment strategies in NSTE-ACS, many randomized controlled trials (RCTs) and meta-analyses have assessed the effects of a routine invasive vs. conservative or selective | Regarding treatment strategies in NSTE-ACS, many randomized controlled trials (RCTs) and meta-analyses have assessed the effects of a routine invasive vs. conservative or selective | ||
invasive approach in the short and long term. One of the most recent meta-analysis has shown a benefit of the routine invasive management that was mainly visisble in intermediate- to high-risk patients. (referentie) | invasive approach in the short and long term. One of the most recent meta-analysis has shown a benefit of the routine invasive management that was mainly visisble in intermediate- to high-risk patients. (referentie) | ||
=== Selective Invasive (“or Conservative”) Management === | === Selective Invasive (“or Conservative”) Management === | ||